Dyne Therapeutics
Kai Wang, Ph.D., serves as a Scientist in Platform Development at Dyne Therapeutics, focusing on the design and synthesis of bioconjugates, alongside optimization and process development. Prior experience includes a Postdoctoral Research Fellowship at Baylor University, where expertise in boron-containing N-heterocyclic carbene ligands was developed for catalysis applications. As a Graduate Researcher at Case Western Reserve University, Kai Wang investigated luminescence in small molecules and contributed to the synthesis of novel polymers. Academic training encompasses a Ph.D. in Chemistry from Case Western Reserve University and a Bachelor's degree from Bryn Mawr College. Additional roles include mentoring students and supervising laboratory personnel throughout various academic positions.